Selected research
Industry Growth & Trends
Global Molecular Pathology Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Molecular Pathology Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Molecular Pathology Services market include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health and Exact Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Molecular Pathology Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Molecular Pathology Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Molecular Pathology Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Molecular Pathology Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Molecular Pathology Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Molecular Pathology Services Market by Company
Quest Diagnostics
Labcorp
Sonic Healthcare
NeoGenomics
Foundation Medicine
Caris Life Sciences
Tempus
Guardant Health
Exact Sciences
Eurofins
Unilabs
Molecular Pathology Services Segment by Type
Solid Tumor Molecular Pathology Services
Hematologic Malignancy Molecular Pathology Services
Hereditary Disease Molecular Pathology Services
Infectious Disease Molecular Testing Services
Rare Disease Molecular Pathology Services
Others
Molecular Pathology Services Segment by Application
Hospitals and Medical Centers
Independent Clinical Laboratories
Academic and Research Institutes
Biopharmaceutical Companies
Others
Molecular Pathology Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Pathology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Pathology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Pathology Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Molecular Pathology Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Tumor Molecular Pathology Services
- Hematologic Malignancy Molecular Pathology Services
- Hereditary Disease Molecular Pathology Services
- Infectious Disease Molecular Testing Services
- Rare Disease Molecular Pathology Services
- Others
Applications
- Hospitals and Medical Centers
- Independent Clinical Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Others
Companies covered
- Quest Diagnostics
- Labcorp
- Sonic Healthcare
- NeoGenomics
- Foundation Medicine
- Caris Life Sciences
- Tempus
- Guardant Health
- Exact Sciences
- Eurofins
- Unilabs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Molecular Pathology Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Molecular Pathology Services Market Size by Region (2021-2032)
- 1.4.1 Global Molecular Pathology Services Market Size by Region (2021-2026)
- 1.4.2 Global Molecular Pathology Services Market Size by Region (2027-2032)
- 1.5 Key Regions Molecular Pathology Services Market Size (2021-2032)
- 1.5.1 North America Molecular Pathology Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Molecular Pathology Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Molecular Pathology Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Molecular Pathology Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Molecular Pathology Services Market Size Growth Rate (2021-2032)
2 Molecular Pathology Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Solid Tumor Molecular Pathology Services
- 2.1.2 Hematologic Malignancy Molecular Pathology Services
- 2.1.3 Hereditary Disease Molecular Pathology Services
- 2.1.4 Infectious Disease Molecular Testing Services
- 2.1.5 Rare Disease Molecular Pathology Services
- 2.1.6 Others
- 2.2 Global Molecular Pathology Services Market Size by Type
- 2.2.1 Global Molecular Pathology Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Molecular Pathology Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Molecular Pathology Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Molecular Pathology Services Market Size by Regions
- 2.3.1 North America Molecular Pathology Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Molecular Pathology Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Molecular Pathology Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Molecular Pathology Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Molecular Pathology Services Market Size Breakdown by Type (2021-2026)
3 Molecular Pathology Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals and Medical Centers
- 3.1.2 Independent Clinical Laboratories
- 3.1.3 Academic and Research Institutes
- 3.1.4 Biopharmaceutical Companies
- 3.1.5 Others
- 3.2 Global Molecular Pathology Services Market Size by Application
- 3.2.1 Global Molecular Pathology Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Molecular Pathology Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Molecular Pathology Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Molecular Pathology Services Market Size by Regions
- 3.3.1 North America Molecular Pathology Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Molecular Pathology Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Molecular Pathology Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Molecular Pathology Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Molecular Pathology Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Molecular Pathology Services Industry Trends
- 4.2 Molecular Pathology Services Industry Drivers
- 4.3 Molecular Pathology Services Industry Opportunities and Challenges
- 4.4 Molecular Pathology Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Molecular Pathology Services Revenue (2021-2026)
- 5.2 Global Molecular Pathology Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Molecular Pathology Services Key Company Headquarters & Area Served
- 5.4 Global Molecular Pathology Services Company, Product Type & Application
- 5.5 Global Molecular Pathology Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Molecular Pathology Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Molecular Pathology Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Molecular Pathology Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Quest Diagnostics
- 6.1.1 Quest Diagnostics Company Information
- 6.1.2 Quest Diagnostics Business Overview
- 6.1.3 Quest Diagnostics Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Quest Diagnostics Molecular Pathology Services Product Portfolio
- 6.1.5 Quest Diagnostics Recent Developments
- 6.2 Labcorp
- 6.2.1 Labcorp Company Information
- 6.2.2 Labcorp Business Overview
- 6.2.3 Labcorp Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Labcorp Molecular Pathology Services Product Portfolio
- 6.2.5 Labcorp Recent Developments
- 6.3 Sonic Healthcare
- 6.3.1 Sonic Healthcare Company Information
- 6.3.2 Sonic Healthcare Business Overview
- 6.3.3 Sonic Healthcare Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sonic Healthcare Molecular Pathology Services Product Portfolio
- 6.3.5 Sonic Healthcare Recent Developments
- 6.4 NeoGenomics
- 6.4.1 NeoGenomics Company Information
- 6.4.2 NeoGenomics Business Overview
- 6.4.3 NeoGenomics Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 NeoGenomics Molecular Pathology Services Product Portfolio
- 6.4.5 NeoGenomics Recent Developments
- 6.5 Foundation Medicine
- 6.5.1 Foundation Medicine Company Information
- 6.5.2 Foundation Medicine Business Overview
- 6.5.3 Foundation Medicine Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Foundation Medicine Molecular Pathology Services Product Portfolio
- 6.5.5 Foundation Medicine Recent Developments
- 6.6 Caris Life Sciences
- 6.6.1 Caris Life Sciences Company Information
- 6.6.2 Caris Life Sciences Business Overview
- 6.6.3 Caris Life Sciences Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Caris Life Sciences Molecular Pathology Services Product Portfolio
- 6.6.5 Caris Life Sciences Recent Developments
- 6.7 Tempus
- 6.7.1 Tempus Company Information
- 6.7.2 Tempus Business Overview
- 6.7.3 Tempus Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Tempus Molecular Pathology Services Product Portfolio
- 6.7.5 Tempus Recent Developments
- 6.8 Guardant Health
- 6.8.1 Guardant Health Company Information
- 6.8.2 Guardant Health Business Overview
- 6.8.3 Guardant Health Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Guardant Health Molecular Pathology Services Product Portfolio
- 6.8.5 Guardant Health Recent Developments
- 6.9 Exact Sciences
- 6.9.1 Exact Sciences Company Information
- 6.9.2 Exact Sciences Business Overview
- 6.9.3 Exact Sciences Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Exact Sciences Molecular Pathology Services Product Portfolio
- 6.9.5 Exact Sciences Recent Developments
- 6.10 Eurofins
- 6.10.1 Eurofins Company Information
- 6.10.2 Eurofins Business Overview
- 6.10.3 Eurofins Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Eurofins Molecular Pathology Services Product Portfolio
- 6.10.5 Eurofins Recent Developments
- 6.11 Unilabs
- 6.11.1 Unilabs Company Information
- 6.11.2 Unilabs Business Overview
- 6.11.3 Unilabs Molecular Pathology Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Unilabs Molecular Pathology Services Product Portfolio
- 6.11.5 Unilabs Recent Developments
7 North America
- 7.1 North America Molecular Pathology Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Molecular Pathology Services Market Size by Country (2021-2026)
- 7.3 North America Molecular Pathology Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Molecular Pathology Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Molecular Pathology Services Market Size by Country (2021-2026)
- 8.3 Europe Molecular Pathology Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Molecular Pathology Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Molecular Pathology Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Molecular Pathology Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Molecular Pathology Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Molecular Pathology Services Market Size by Country (2021-2026)
- 10.3 South America Molecular Pathology Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Molecular Pathology Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Molecular Pathology Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Molecular Pathology Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst